MX349802B - Uso de aril- y hetarilcarboxamidas como endoparasiticidas. - Google Patents
Uso de aril- y hetarilcarboxamidas como endoparasiticidas.Info
- Publication number
- MX349802B MX349802B MX2014006136A MX2014006136A MX349802B MX 349802 B MX349802 B MX 349802B MX 2014006136 A MX2014006136 A MX 2014006136A MX 2014006136 A MX2014006136 A MX 2014006136A MX 349802 B MX349802 B MX 349802B
- Authority
- MX
- Mexico
- Prior art keywords
- hetaryl
- carboxamides
- aryl
- endoparasiticides
- cyclyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente solicitud se refiere a aril- y hetarilcarboxamidas conocidas y nuevas de la fórmula (I) (ver Fórmula) y a su uso como medicamentos para combatir endoparásitos en animales o en seres humanos, y también a composiciones parasiticidas, en particular endoparasiticidas que comprenden aril- y hetarilcarboxamidas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11190735 | 2011-11-25 | ||
PCT/EP2012/073431 WO2013076230A1 (de) | 2011-11-25 | 2012-11-23 | Verwendung von aryl- und hetarylcarboxamiden als endoparasitizide |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014006136A MX2014006136A (es) | 2014-07-28 |
MX349802B true MX349802B (es) | 2017-08-14 |
Family
ID=47216313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014006136A MX349802B (es) | 2011-11-25 | 2012-11-23 | Uso de aril- y hetarilcarboxamidas como endoparasiticidas. |
Country Status (18)
Country | Link |
---|---|
US (1) | US9422276B2 (es) |
EP (1) | EP2782565B1 (es) |
JP (1) | JP6126115B2 (es) |
CN (1) | CN104203223A (es) |
AR (1) | AR088984A1 (es) |
AU (3) | AU2012342433A1 (es) |
BR (1) | BR112014012589A2 (es) |
DK (1) | DK2782565T3 (es) |
ES (1) | ES2762249T3 (es) |
HR (1) | HRP20192191T1 (es) |
HU (1) | HUE047738T2 (es) |
LT (1) | LT2782565T (es) |
MX (1) | MX349802B (es) |
PL (1) | PL2782565T3 (es) |
PT (1) | PT2782565T (es) |
RU (1) | RU2638830C2 (es) |
SI (1) | SI2782565T1 (es) |
WO (1) | WO2013076230A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2891492T3 (da) * | 2012-08-30 | 2022-11-21 | Univ Tokyo | Endoparasit kontrol middel |
TWI598325B (zh) * | 2012-10-12 | 2017-09-11 | H 朗德貝克公司 | 苯甲醯胺類 |
TW201507722A (zh) * | 2013-04-30 | 2015-03-01 | Bayer Cropscience Ag | 做為殺線蟲劑及殺體內寄生蟲劑的n-(2-鹵素-2-苯乙基)-羧醯胺類 |
WO2015004091A1 (en) | 2013-07-12 | 2015-01-15 | Syngenta Participations Ag | Nicotinamide derivatives and their use against nematodes |
CA2917289A1 (en) * | 2013-07-18 | 2015-01-22 | Syngenta Participations Ag | Pyridine-2-carboxamides as nematocides |
UY35772A (es) | 2013-10-14 | 2015-05-29 | Bayer Cropscience Ag | Nuevos compuestos plaguicidas |
DK3115051T3 (da) * | 2014-03-05 | 2022-07-04 | Univ Tokyo | Endoparasit kontrol agens |
UY36196A (es) | 2014-07-25 | 2016-02-29 | Bayer Animal Health Gmbh | Compuestos para usar en el tratamiento antihelmíntico |
GB201415569D0 (en) | 2014-09-03 | 2014-10-15 | C4X Discovery Ltd | Therapeutic Compounds |
BR112017008496A2 (pt) | 2014-10-28 | 2017-12-26 | Bayer Animal Health Gmbh | compostos para uso em tratamento antelmíntico |
BR112018003515A2 (pt) * | 2015-09-04 | 2018-09-18 | Dow Agrosciences Llc | moléculas tendo utilidade pesticida, e intermediários, composições e processos relacionados às mesmas |
KR102668676B1 (ko) * | 2015-12-30 | 2024-05-24 | 이아이디피, 인크. | 살선충성 헤테로환 아미드 |
GB201601703D0 (en) | 2016-01-29 | 2016-03-16 | C4X Discovery Ltd | Therapeutic compounds |
AU2019215799B2 (en) * | 2018-02-01 | 2022-04-14 | The University Of Sydney | Anti-cancer compounds |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4504484A (en) * | 1982-11-04 | 1985-03-12 | Chevron Research Company | Certain N,N-di-substituted-pyridine carboxamides, fungicidal compositions and fungicidal method of use |
GB8403726D0 (en) * | 1984-02-13 | 1984-03-14 | Shell Int Research | Carboxamide derivatives |
JPS6150969A (ja) * | 1984-08-20 | 1986-03-13 | Nippon Kayaku Co Ltd | ピリジン誘導体及びそれを有効成分とする農園芸用細菌病防除剤 |
DD247598A5 (de) * | 1985-04-04 | 1987-07-15 | F. Hoffmann-La Roche U. Co. Ag,Ch | Fungizide mittel |
DE4032147A1 (de) | 1990-10-10 | 1992-04-16 | Bayer Ag | Verwendung von substituierten 2-mercaptonicotinsaeurederivaten zur bekaempfung von endoparasiten, neue substituierte 2-mercaptonicotinsaeurederivate und verfahren zu ihrer herstellung |
DE4400464A1 (de) * | 1994-01-11 | 1995-07-13 | Bayer Ag | Endoparasitizide Mittel |
JPH09249648A (ja) * | 1996-03-18 | 1997-09-22 | Dainippon Ink & Chem Inc | 2,6−ジクロロイソニコチン酸フェノキシアルキルアミド誘導体及び農薬 |
DE19750012A1 (de) | 1997-11-12 | 1999-05-20 | Bayer Ag | Isothiazolcarbonsäureamide |
NZ518931A (en) * | 1999-12-02 | 2004-02-27 | Novartis Ag | Aminoheterocyclyamides as Pesticides and Antiparasitic Agents |
CN1226277C (zh) | 2000-02-16 | 2005-11-09 | 石原产业株式会社 | 苯甲酰甲胺衍生物及其制法和含这些衍生物的有害生物防治剂 |
JP2001316366A (ja) * | 2000-03-01 | 2001-11-13 | Nippon Bayer Agrochem Co Ltd | チオカルボキシアミド類及びその農業用殺菌剤として利用 |
KR100850252B1 (ko) * | 2000-12-20 | 2008-08-04 | 노파르티스 아게 | 유기 화합물 |
US7067315B2 (en) | 2001-05-22 | 2006-06-27 | President And Fellows Of Harvard College | Identification of anti-protozoal agents |
TW200305556A (en) | 2002-03-21 | 2003-11-01 | Novartis Ag | Organic compounds |
ES2250921T3 (es) | 2002-08-12 | 2006-04-16 | Bayer Cropscience S.A. | Nuevo derivado de 2-piridiletilbenzamida. |
EP1449841A1 (en) | 2003-02-19 | 2004-08-25 | Bayer CropScience SA | New fungicidal compounds |
DE10307845A1 (de) * | 2003-02-25 | 2004-09-02 | Bayer Cropscience Gmbh | Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel |
EP1500651A1 (en) | 2003-07-25 | 2005-01-26 | Bayer CropScience S.A. | N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides |
AR046757A1 (es) * | 2003-12-10 | 2005-12-21 | Novartis Ag | Amidoacetonitrilos utiles como pesticidas |
TWI368482B (en) | 2003-12-19 | 2012-07-21 | Bayer Sas | New 2-pyridinylethylbenzamide derivatives |
EP1548007A1 (en) | 2003-12-19 | 2005-06-29 | Bayer CropScience S.A. | 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
EP1574511A1 (en) | 2004-03-03 | 2005-09-14 | Bayer CropScience S.A. | 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
EP1710237A1 (en) | 2005-04-08 | 2006-10-11 | Bayer CropScience S.A. | New heterocyclylethylbenzamide derivatives |
EP1879878B1 (en) | 2005-04-08 | 2014-06-25 | Bayer CropScience AG | Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides |
US20060276515A1 (en) * | 2005-05-06 | 2006-12-07 | Cywin Charles L | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same |
EP1787981A1 (en) * | 2005-11-22 | 2007-05-23 | Bayer CropScience S.A. | New N-phenethylcarboxamide derivatives |
EP1792901A1 (en) | 2005-11-22 | 2007-06-06 | Bayer CropScience S.A. | N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
US7951973B2 (en) | 2005-11-22 | 2011-05-31 | Bayer Cropscience Ag | N-(1-methyl-2Phenylethyl)benzamide derivatives |
US7790770B2 (en) | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
TWI435863B (zh) | 2006-03-20 | 2014-05-01 | Nihon Nohyaku Co Ltd | N-2-(雜)芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑 |
CL2008000512A1 (es) | 2007-02-22 | 2008-08-29 | Bayer Cropscience Sa | Compuestos derivados de n-(3-fenilpropil)carboxamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos. |
KR101050445B1 (ko) | 2007-04-12 | 2011-07-19 | 니혼노야쿠가부시키가이샤 | 살선충제 조성물 및 그 사용 방법 |
CL2008001647A1 (es) | 2007-06-08 | 2008-10-10 | Syngenta Participations Ag | Compuestos derivados de feniletil-amida de acido-1h-pirazol-4-carboxilico; compuestos derivados de (feniletil)amina; metodo para controlar o prevenir la infestacion de plantas por parte de microorganismos fitopatogenos; y composicion para el control |
JP2011507910A (ja) | 2007-12-21 | 2011-03-10 | ユニバーシティー オブ ロチェスター | 真核生物の寿命を変更するための方法 |
EA018605B1 (ru) | 2008-08-01 | 2013-09-30 | Байер Кропсайенс Аг | Фунгицидные n-(2-феноксиэтил)карбоксамидные производные и их аза-, тиа- и силааналоги |
MY152114A (en) | 2008-12-05 | 2014-08-15 | Syngenta Participations Ag | Novel pyrazole-4-n-alkoxycarboxamides as microbiocides |
EP2445866A2 (en) * | 2009-06-24 | 2012-05-02 | Shire LLC | Mexiletine amino acid and peptide prodrugs and uses thereof |
UY33282A (es) * | 2010-03-25 | 2011-09-30 | Novartis Ag | Composiciones endoparasiticidas |
WO2011128989A1 (ja) | 2010-04-14 | 2011-10-20 | アグロカネショウ株式会社 | ピラジン-2-カルボキサミド誘導体及びこれを有効成分とする殺菌剤 |
RU2596788C2 (ru) * | 2011-03-02 | 2016-09-10 | Нихон Нохияку Ко., Лтд. | Средство для борьбы с эндопаразитами |
MX2014005197A (es) * | 2011-11-04 | 2014-05-28 | Syngenta Participations Ag | Compuestos plaguicidas. |
-
2012
- 2012-11-23 CN CN201280067982.5A patent/CN104203223A/zh active Pending
- 2012-11-23 PT PT127885739T patent/PT2782565T/pt unknown
- 2012-11-23 WO PCT/EP2012/073431 patent/WO2013076230A1/de active Application Filing
- 2012-11-23 SI SI201231697T patent/SI2782565T1/sl unknown
- 2012-11-23 JP JP2014542842A patent/JP6126115B2/ja active Active
- 2012-11-23 US US14/360,332 patent/US9422276B2/en active Active
- 2012-11-23 BR BR112014012589A patent/BR112014012589A2/pt not_active Application Discontinuation
- 2012-11-23 LT LTEP12788573.9T patent/LT2782565T/lt unknown
- 2012-11-23 PL PL12788573T patent/PL2782565T3/pl unknown
- 2012-11-23 MX MX2014006136A patent/MX349802B/es active IP Right Grant
- 2012-11-23 AR ARP120104427A patent/AR088984A1/es active Pending
- 2012-11-23 DK DK12788573.9T patent/DK2782565T3/da active
- 2012-11-23 RU RU2014125466A patent/RU2638830C2/ru not_active IP Right Cessation
- 2012-11-23 AU AU2012342433A patent/AU2012342433A1/en not_active Abandoned
- 2012-11-23 ES ES12788573T patent/ES2762249T3/es active Active
- 2012-11-23 EP EP12788573.9A patent/EP2782565B1/de not_active Not-in-force
- 2012-11-23 HU HUE12788573A patent/HUE047738T2/hu unknown
-
2017
- 2017-10-06 AU AU2017239594A patent/AU2017239594A1/en not_active Abandoned
-
2019
- 2019-04-30 AU AU2019203000A patent/AU2019203000A1/en not_active Abandoned
- 2019-12-04 HR HRP20192191TT patent/HRP20192191T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2762249T3 (es) | 2020-05-22 |
PT2782565T (pt) | 2020-01-07 |
JP6126115B2 (ja) | 2017-05-10 |
RU2014125466A (ru) | 2015-12-27 |
MX2014006136A (es) | 2014-07-28 |
JP2015504437A (ja) | 2015-02-12 |
DK2782565T3 (da) | 2020-01-02 |
PL2782565T3 (pl) | 2020-08-24 |
BR112014012589A2 (pt) | 2017-06-20 |
US20140323736A1 (en) | 2014-10-30 |
HRP20192191T1 (hr) | 2020-02-21 |
CN104203223A (zh) | 2014-12-10 |
LT2782565T (lt) | 2019-12-27 |
RU2638830C2 (ru) | 2017-12-18 |
WO2013076230A1 (de) | 2013-05-30 |
AU2012342433A1 (en) | 2014-06-12 |
SI2782565T1 (sl) | 2019-12-31 |
EP2782565A1 (de) | 2014-10-01 |
NZ624536A (en) | 2016-09-30 |
US9422276B2 (en) | 2016-08-23 |
AR088984A1 (es) | 2014-07-23 |
HUE047738T2 (hu) | 2020-05-28 |
EP2782565B1 (de) | 2019-11-06 |
AU2019203000A1 (en) | 2019-05-23 |
AU2017239594A1 (en) | 2017-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX349802B (es) | Uso de aril- y hetarilcarboxamidas como endoparasiticidas. | |
HRP20190164T1 (hr) | Paraziticidni oralni veterinarski sastavi koji obuhvaćaju djelatne tvari sa sustavnim djelovanjem, i načini njihove primjene | |
TN2015000278A1 (en) | Autotaxin inhibitors | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
BR112015029970A2 (pt) | inibidores de cinase | |
HK1221653A1 (zh) | 用於呼吸遞送三種或更多種活性劑的組合物、方法和系統 | |
IL229260A0 (en) | Preparations, methods and systems for respiratory administration of two or more active agents | |
PH12018502580A1 (en) | Formulations for paddy rice fields | |
MX2013012652A (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12. | |
EP3133073A3 (en) | Inhibitors of iap | |
MX2014001604A (es) | Compuestos de antranilamida y sus usos como plaguicidas. | |
PH12015501054A1 (en) | Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides | |
MX2014001510A (es) | Compuestos de antranilamida y sus usos como plaguicidas. | |
WO2012080641A8 (fr) | Agonistes des recepteurs s1p et leur utilisation dans le traitement des infections du vih | |
MX2013004878A (es) | N-hetarilmetil pirazolilcarboxamidas. | |
WO2012024634A3 (en) | Environmentally-responsive nanocomposites and methods of their use | |
WO2011103028A3 (en) | Compositions and methods for inhibiting mmset | |
TN2015000045A1 (en) | Tris(hetero)arylpyrazoles and use thereof | |
MX367773B (es) | Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
WO2012174164A3 (en) | Agonists of gpr131 and uses thereof | |
TH1101003388B (th) | องค์ประกอบ วิธีการและระบบเพื่อการส่งสารตัวกระทำปลุกฤทธิ์สองชนิดหรือมากกว่าทางการหายใจ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |